They've got exclusion for the virus on 90% of their contracts. Listen to the last CC. Long and strong!
1
Too cheap here imo
A
How much would mortgage defaults impact this stock?
k
saw this in Eisai news feed. pretty amazing to remove all plaques in a year. does this "cure" AZ, I dunno.
Eisai Co., Ltd. (Pink: ESALY) and Biogen, Inc. (NASDAQ: BIIB) announced results of new clinical, biomarker and safety assessments of brain amyloid reduction and five-year clinical status of people living with early Alzheimer's disease from the lecanemab Phase 2b 201 and the open-label extension studies.
The findings, presented in a late-breaking roundtable session with clinical researchers at the 2021 Clinical Trials on Alzheimer's Disease conference, showed treatment with lecanemab resulted in reduction of brain amyloid levels in as early as three months and robust clearance of amyloid plaque with more than 80% of participants achieving amyloid negative status by 12-18 months of treatment as measured by PET.
Eisai Co., Ltd. (Pink: ESALY) and Biogen, Inc. (NASDAQ: BIIB) announced results of new clinical, biomarker and safety assessments of brain amyloid reduction and five-year clinical status of people living with early Alzheimer's disease from the lecanemab Phase 2b 201 and the open-label extension studies.
The findings, presented in a late-breaking roundtable session with clinical researchers at the 2021 Clinical Trials on Alzheimer's Disease conference, showed treatment with lecanemab resulted in reduction of brain amyloid levels in as early as three months and robust clearance of amyloid plaque with more than 80% of participants achieving amyloid negative status by 12-18 months of treatment as measured by PET.
remember when the donald promised? lolz!